Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Atypical Depression
Interventions
DRUG

Escitalopram

Escitalopram will be started at 10 mg per day and augmented weekly in 10 mg per day increments, the maximum dose being 20 mg per day. The dose will be titrated upward or downward based on clinical response and tolerability.

Trial Locations (1)

27705

Dept Psychiatry, Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Duke University

OTHER

NCT00610506 - Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features | Biotech Hunter | Biotech Hunter